IQAI Stock Overview
Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
IQ-AI Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.016 |
52 Week High | UK£0.051 |
52 Week Low | UK£0.0093 |
Beta | 2.4 |
1 Month Change | 45.45% |
3 Month Change | 33.33% |
1 Year Change | -56.16% |
3 Year Change | -72.77% |
5 Year Change | -65.96% |
Change since IPO | -55.86% |
Recent News & Updates
Shareholder Returns
IQAI | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 10.3% | 1.4% | -0.2% |
1Y | -56.2% | 21.3% | 6.9% |
Return vs Industry: IQAI underperformed the UK Healthcare Services industry which returned 26.1% over the past year.
Return vs Market: IQAI underperformed the UK Market which returned 6.2% over the past year.
Price Volatility
IQAI volatility | |
---|---|
IQAI Average Weekly Movement | 10.5% |
Healthcare Services Industry Average Movement | 5.0% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 10.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: IQAI's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: IQAI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1965 | 7 | Trevor Brown | www.iqai.ltd |
IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018.
IQ-AI Limited Fundamentals Summary
IQAI fundamental statistics | |
---|---|
Market cap | UK£3.55m |
Earnings (TTM) | -UK£597.65k |
Revenue (TTM) | UK£770.99k |
4.6x
P/S Ratio-5.9x
P/E RatioIs IQAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IQAI income statement (TTM) | |
---|---|
Revenue | UK£770.99k |
Cost of Revenue | UK£9.64k |
Gross Profit | UK£761.34k |
Other Expenses | UK£1.36m |
Earnings | -UK£597.65k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0027 |
Gross Margin | 98.75% |
Net Profit Margin | -77.52% |
Debt/Equity Ratio | 0% |
How did IQAI perform over the long term?
See historical performance and comparison